3 Results for "

EGFR-IN-39

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "EGFR-IN-39" in MCE Product Catalog:

Cat. No.: HY-144056
CAS No.: 2711105-48-3
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-39 is a potent inhibitor of EGFR. EGFR-IN-39 is an anti-tumor agent with low toxic side effects. EGFR-IN-39 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-39 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 2) .
loading...
    loading...
Cat. No.: HY-157581
CAS No.: 2675490-92-1
Purity:  99.89%
Target:  

EGFR PROTACs

Research Areas:  

Cancer

MS39 (compound 6) is a PROTAC targeting EGFR. MS39 reduces the expression of EGFR and downstream signaling in HCC-827 and H3255 cells. MS39 inhibits the proliferation of H3255 cells .
loading...
    loading...
Cat. No.: HY-144054
CAS No.: 2711105-53-0
Target:  

EGFR

Research Areas:  

Cancer

EGFR-IN-37 is a potent inhibitor of EGFR. EGFR-IN-37 is an anti-tumor agent with low toxic side effects. EGFR-IN-39 is an acrylamide derivative compound. Overexpression and mutation of the epidermal growth factor receptor (EGFR) has been clearly demonstrated to lead to uncontrollable cell growth and is associated with the progression of most cancer diseases, especially NSCLC. EGFR-IN-37 has the potential for the research of diseases associated with EGFR mutations (extracted from patent WO2021185348A1, compound 7) .
loading...
    loading...